Regulation of monocyte/macrophage function by factor VII activating protease (FSAP).

[1]  J. Jukema,et al.  The Marburg I polymorphism of factor VII activating protease is associated with low proteolytic and low pro-coagulant activity. , 2012, Thrombosis research.

[2]  R. Weiskirchen,et al.  Circulating factor VII activating protease (FSAP) is associated with clinical outcome in acute coronary syndrome. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[3]  S. Kanse,et al.  At the interface of fibrinolysis and inflammation: the role of urokinase-type plasminogen activator in the leukocyte extravasation cascade. , 2012, Trends in cardiovascular medicine.

[4]  P. Bugert,et al.  The G534E-polymorphism of the gene encoding the factor VII-activating protease is a risk factor for venous thrombosis and recurrent events. , 2012, Thrombosis research.

[5]  C. Blomstrand,et al.  Plasma factor VII‐activating protease antigen levels and activity are increased in ischemic stroke , 2012, Journal of thrombosis and haemostasis : JTH.

[6]  S. Denk,et al.  Factor VII-Activating Protease Is Activated in Multiple Trauma Patients and Generates Anaphylatoxin C5a , 2012, The Journal of Immunology.

[7]  P. Declerck,et al.  Factor VII–Activating Protease Promotes the Proteolysis and Inhibition of Tissue Factor Pathway Inhibitor , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[8]  A. Khera,et al.  Interactions Between Smoking, Pulmonary Surfactant Protein B, and Atherosclerosis in the General Population: The Dallas Heart Study , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[9]  K. Hasumi,et al.  Extracellular histone induces plasma hyaluronan-binding protein (factor VII activating protease) activation in vivo. , 2011, Biochemical and biophysical research communications.

[10]  H. ten Cate,et al.  The hemostatic system as a modulator of atherosclerosis. , 2011, The New England journal of medicine.

[11]  M. Boermeester,et al.  Activation of factor VII-activating protease in human inflammation: a sensor for cell death , 2011, Critical care.

[12]  H. Waldmann,et al.  Activation of the Raf-MEK-ERK pathway is required for neutrophil extracellular trap formation. , 2011, Nature chemical biology.

[13]  S. Walmsley,et al.  Distinct Cell Death Programs in Monocytes Regulate Innate Responses Following Challenge with Common Causes of Invasive Bacterial Disease , 2010, The Journal of Immunology.

[14]  R. Weiskirchen,et al.  Factor seven ativating potease (FSAP) levels during normal pregnancy and in women using oral contraceptives. , 2010, Thrombosis research.

[15]  E. Plow,et al.  Plasminogen and its receptors as regulators of cardiovascular inflammatory responses. , 2010, Trends in cardiovascular medicine.

[16]  Frances E. Lennon,et al.  Hyaluronic Acid Binding Protein 2 Is a Novel Regulator of Vascular Integrity , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[17]  Yoshihisa Okamoto,et al.  Inflammation in atherosclerosis: transition from theory to practice. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[18]  L. Aarden,et al.  Nucleosome‐releasing factor: a new role for factor VII‐activating protease (FSAP) , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  K. Preissner,et al.  The G534E polymorphism of the gene encoding the factor VII–activating protease is associated with cardiovascular risk due to increased neointima formation , 2006, The Journal of experimental medicine.

[20]  B. Horne,et al.  Which white blood cell subtypes predict increased cardiovascular risk? , 2005, Journal of the American College of Cardiology.

[21]  M. Hofker,et al.  Nuclear Factor &kgr;B Signaling in Atherogenesis , 2005 .

[22]  T. Dörner,et al.  Marburg I polymorphism of factor VII-activating protease is associated with idiopathic venous thromboembolism. , 2005, Blood.

[23]  V. Fuster,et al.  The year in atherothrombosis. , 2004, Journal of the American College of Cardiology.

[24]  D. Waters,et al.  Role of thrombotic and fibrinolytic factors in acute coronary syndromes. , 2004, Progress in cardiovascular diseases.

[25]  S. Blankenberg,et al.  Adhesion molecules and atherosclerosis. , 2003, Atherosclerosis.

[26]  S. Kiechl,et al.  Marburg I Polymorphism of Factor VII–Activating Protease: A Prominent Risk Predictor of Carotid Stenosis , 2003, Circulation.

[27]  M. Voskuil,et al.  Local Monocyte Chemoattractant Protein-1 Therapy Increases Collateral Artery Formation in Apolipoprotein E–Deficient Mice but Induces Systemic Monocytic CD11b Expression, Neointimal Formation, and Plaque Progression , 2003, Circulation research.

[28]  Yu-ling,et al.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.

[29]  James L. Young,et al.  Cytokines in the Pathogenesis of Atherosclerosis , 2002, Thrombosis and Haemostasis.

[30]  K. Preissner,et al.  Factor VII and single-chain plasminogen activator-activating protease: activation and autoactivation of the proenzyme. , 2001, European journal of biochemistry.

[31]  J. Römisch,et al.  A protease isolated from human plasma activating factor VII independent of tissue factor. , 1999, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[32]  R. Ross,et al.  Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[33]  R. Ross,et al.  Atherosclerosis is an Inflammatory Disease , 1998 .

[34]  T. Tobe,et al.  Purification and characterization of a novel hyaluronan-binding protein (PHBP) from human plasma: it has three EGF, a kringle and a serine protease domain, similar to hepatocyte growth factor activator. , 1996, Journal of biochemistry.

[35]  L. Aarden,et al.  FSAP, a new player in inflammation? , 2012, Hämostaseologie.

[36]  S. Kanse,et al.  Nicotine modulation of factor VII activating protease (FSAP) expression in human monocytes. , 2012, Journal of atherosclerosis and thrombosis.

[37]  R. Bohle,et al.  Factor Seven Activating Protease (FSAP) expression in human monocytes and accumulation in unstable coronary atherosclerotic plaques. , 2008, Atherosclerosis.

[38]  J. Paramo,et al.  Matrix Metalloproteinase-9 : Implications for Human Atherosclerosis Phagocytic NADPH Oxidase-Dependent Superoxide Production Stimulates , 2007 .